Medtech firms TestCard and SureScreen have collaborated with Guy’s and St Thomas’ NHS Foundation Trust on the new TestCard’s ClearScreen app, which is designed to help with the process of COVID-19 antigen testing and the recording of test results.
The smartphone app is designed to enable the phone to function as a clinical-grade scanner, capturing and scanning information from lateral flow tests. The app doesn’t require manual recording, simply giving a positive, negative or invalid result.
The app also securely and safely stores the result, ensuring compliance with reporting requirements from Public Health England. The solution is set to be piloted by Guys’ and St Thomas’ on inpatients, with plans for the app to be extended to out-patient appointments.
Dr Rahul Batra from Guy's and St Thomas' Centre for Clinical Infection and Diagnostics Research said: “Lateral flow devices have always had the potential to play an important role in COVID-19 disease surveillance and early diagnosis. However, in the clinical space they have been hampered by their ability to be administered, interpreted, and reported in an automated and standardised fashion to the patient record.”
“We have worked closely with TestCard and SureScreen to not only create a highly sensitive and specific LFD but to also develop the corresponding reporting application that allows for the trained users to administer the test, return a standard interpretation, and provide an automated and reviewable result to the patient record.”
“As LFD testing is now a core component of any patient pathway at Guy’s and St Thomas’ requiring an admission, a significant procedure or an intervention involving the airway, we feel that the introduction of this application will lead to improved patient/visitor flow and safety, thus allowing us to offer a wider range of inpatient and outpatient services to our community.”